Cronos Group Inc. (CRON)
| Market Cap | 1.33B +42.1% |
| Revenue (ttm) | 206.20M +55.8% |
| Net Income | 57.83M +60.2% |
| EPS | 0.16 +63.7% |
| Shares Out | 366.47M |
| PE Ratio | 23.29 |
| Forward PE | 18.11 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,315,983 |
| Open | 3.700 |
| Previous Close | 3.720 |
| Day's Range | 3.550 - 3.705 |
| 52-Week Range | 2.280 - 3.910 |
| Beta | 1.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |
About CRON
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Financial Performance
Financial StatementsNews
Cronos Group (CRON) Q3 2026 Earnings Call Transcript
European expansion and Canadian brand strength drove a record quarter.
Cronos Group Q3 Earnings Call Highlights
Cronos Group NASDAQ: CRON reported record third-quarter revenue, gross profit and adjusted EBITDA as cannabis sales grew in Israel, Canada and Germany, while executives outlined plans to expand in Eur...
Cronos Group reports Q3 revenue $63.5M vs. $36.3M last year
Reports Q3 gross profit $32.3M vs. $18.3M last year. Reports Q3 net income $17.8M vs. $28.3M last year. Reports Q3 adjusted EBITDA $17.1M vs. $5.7M last year. “Cronos organically achieved…
Cronos Group Inc Q3 Income Retreats
(RTTNews) - Cronos Group Inc (CRON) released a profit for third quarter that Dropped, from the same period last year
Cronos Group Earnings Call Transcript: Q3 2026
Q3 delivered record revenue, gross profit, and Adjusted EBITDA, with 75% revenue growth and strong regional performance. The October CanAdelaar acquisition adds a Netherlands platform, while price compression and export timing remain factors.
Cronos Group Earnings release: Q3 2026
Cronos Group released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Cronos Group Quarterly report: Q3 2026
Cronos Group has published its Q3 2026 quarterly earnings report on November 5, 2026.
Cronos Group Report: Q3 2026
Cronos Group published a report on November 5, 2026 containing material business information for investors and shareholders.
Cronos Group MD&A: Q3 2026
Cronos Group filed a regulatory document on November 5, 2026 disclosing important business information.
Cronos Group Earnings release: Q3 2026
Cronos Group released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Cronos Group Reports 2026 Third Quarter Results
Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count
Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company
Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA 1 in 2026 and 2027
Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season
TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bri...
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2...
Cronos Group price target raised to C$7 from C$6 at TD Securities
TD Securities raised the firm’s price target on Cronos Group (CRON) to C$7 from C$6 and keeps a Buy rating on the shares.
Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions
Cronos Group NASDAQ: CRON used its first Investor Day to outline its cultivation, genetics, brand and financial strategy, emphasizing its purpose-built greenhouse partnership with Mucci Farms, continu...
Cronos Group Transcript: Investor Day 2026
A purpose-built, data-driven approach to cultivation and genetics underpins strong revenue growth, market leadership in edibles and vapes, and expanding international presence. Financial discipline and a robust cash position support ongoing innovation and readiness for future expansion.
Cronos Group Slides: FY 2026
Cronos Group has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 24, 2026.
Cronos Hosts 2026 Investor Day
TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026,...
Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026 Registration is now open for Cronos' first Investor Day, which will b...
Cronos' brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ ...
The Best Way Marijuana Stock Investing Can Work For You
As the cannabis industry continues to grow worldwide, there is a strong focus on the future. Many new changes are occurring throughout the sector—many of these impact businesses, investors, and potent...
Surging Earnings Estimates Signal Upside for Cronos (CRON) Stock
Cronos Group (CRON) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle
With November's pivotal midterm elections fast approaching, cannabis reform is emerging as an issue. Two states, Massachusetts and Idaho, will vote on ballot initiatives regarding legalization, and in...
Cronos (CRON) Q2 2026 Earnings Call Transcript
Record revenue and EBITDA growth fueled by Canadian retail and international expansion.